|Title||Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Vivante, A, Chacham, OStaretz, Shril, S, Schreiber, R, Mane, SM, Pode-Shakked, B, Soliman, NA, Koneth, I, Schiffer, M, Anikster, Y, Hildebrandt, F|
|Date Published||2019 Sep|
BACKGROUND: Heterozygous PAX2 mutations cause renal coloboma syndrome (RCS) [OMIM no. 120330]. RCS is a renal syndromic disease encompassing retinal coloboma and sensorineural hearing loss. Recently, a causative role for PAX2 was reported in adult-onset nephrotic syndrome secondary to focal segmental glomerulosclerosis (FSGS). However, the prevalence of PAX2 mutations among large cohort of children with steroid-resistant nephrotic syndrome (SRNS) and FSGS has not been systematically studied.
METHODS: We employed whole-exome sequencing (WES) to identify the percentage of SRNS cases explained by monogenic mutations in known genes of SRNS/FSGS. As PAX2 mutations are not an established cause of childhood FSGS, we evaluated a cohort of 215 unrelated families with SRNS, in whom no underlying genetic etiology had been previously established.
RESULTS: Using WES, we identified 3 novel causative heterozygous PAX2 mutations in 3 out of the 215 unrelated index cases studied (1.3%). All three cases were detected in individuals from families with more than one affected and compatible with an autosomal dominant mode of inheritance (3/57 familial cases studied (5.2%)). The clinical diagnosis in three out of four pediatric index patients was done during routine medical evaluation.
CONCLUSIONS: Our findings demonstrate high frequency of PAX2 mutations in familial form of SRNS (5.2%) and further expand the phenotypic spectrum of PAX2 heterozygous mutations to include autosomal dominant childhood-onset FSGS. These results highlight the importance of including PAX2 in the list of genes known to cause FSGS in children.
|Alternate Journal||Pediatr. Nephrol.|
|PubMed Central ID||PMC6660980|
|Grant List||R01 DK076683 / DK / NIDDK NIH HHS / United States |
S10 OD018521 / OD / NIH HHS / United States
R01-DK076683 / NH / NIH HHS / United States
UM1 HG008900 to DGM and HLR and U54 HG006504 to RPL) / NH / NIH HHS / United States